Experts discuss the ease of use and advantages to using a harmonized approach of Nuclear Magnetic Resonance and Mass Spectroscopy for the detection and identification of narcotics.

Detection of illegal drugs is an ongoing battle and the rapid analysis and identification of prohibited substances is critical to prevent their importation and widespread distribution. Additionally, the data generated needs to be significantly robust for submission in court cases. In most countries across the globe, a minimum of two orthogonal analytical methods must be used in drug testing to provide detailed and admissible evidence. Nuclear Magnetic Resonance and Mass Spectrometry are well established key methods for narcotics analysis, and operate on fundamentally different scientific principles, thus providing definitive identifications. Both methods validate each other and are now brought to your lab bench by Bruker. Today, Bruker’s powerful approach provides enhanced ease of use and maximized method compliance. Bruker supports leading law enforcement authorities worldwide. Become part of the community!This webinar will be of particular interest to those working in forensic laboratories, law enforcement authorities, customs & border protection agencies, regulatory bodies, official control laboratories and undertaking analysis of narcotics or suspected narcotics.

Key Topics Include:

  • Increase evidence robustness by application of orthogonal methods
  • Take advantage of training and maintenance synergies from one single point of contact
  • Enhance ease of use and through put with harmonized methods
  • Shorten time to result with benchtop instruments in every local laboratory

Presenters

Joerg Koehler, ;PhD

Joerg Koehler, PhD

Head of Business Unit Industrial
Bruker BioSpin

Dr. Joerg Koehler studied physics and holds a doctoral degree from the Institute of Biophysics and Physical Biochemistry of the University of Regensburg. His research focused on High-Pressure-NMR based studies of folding intermediates of biochemically active macromolecules. After several positions in sales, sales management and business administration he joined Bruker as Head of Business Unit Industrial. Today Dr Joerg Koehler is accountable for Bruker’s global activities in magnetic resonance in various industrial market segments including forensics.
Venita Decker, ;PhD

Venita Decker, PhD

Product Manager FT-NMR Benchtop Solutions
Bruker BioSpin

Dr. Venita Decker studied Neuroscience, but did her dissertation in the field of solid-state NMR (Max Planck Institute for Biophysical Chemistry, Goettingen). In 2012, she joined the Bruker solid-state NMR application. As a NMR-late entrant she since then actively supported Bruker solutions that simplify the complexity of NMR (TopSolids, the minispec FormCheck). Since 2018, she is the Product Manager for FT-NMR benchtop solutions, bringing her mission to the next level.
Andrea Kiehne, ;PhD

Andrea Kiehne, PhD

Applied Solutions, Demo Team Leader & Toxtyper Specialist
Bruker BioSpin

Head of Bremen Applied Solutions Demo Team 1997 Post Doc, University of Braunschweig, Germany, 1996 PhD in Food Chemistry, University of Braunschweig, Germany With Bruker Daltonik since 1998, her core competences are Toxtyper and TargetScreener solutions; forensic, food, environmental and industrial applications using ion trap, QTOF and timsTOF
Watch Webinar

Webinar Host

Bruker Corporation

Bruker offers preclinical imaging solutions for a broad spectrum of application fields, such as cancer research, neuroimaging and cardiac disease.

VIEW PROFILE
Bruker Corporation

Additional Content From Bruker Corporation

Related Content